Porphyrinogenic drugs can cause changes in heme metabolism, leading to increases in porphyrin levels in biological fluids and exacerbation of the course of porphyrias. The sites at which porphyrins and their precursors accumulate determine the course and clinical picture of porphyrias, i.e., liver (hepatic types) and bone marrow (erythropoietic types). Porphyria biomarkers are found in urine, feces, and plasma. A reverse phase HPLC technique with UV detection was validated. Qualitative and quantitative assessment of the composition of heme precursors (nine markers + internal standard) in blood plasma was carried out on a Waters Acquity UPLC H-CLASS system with a diode array detector.
Similar content being viewed by others
References
D. A. Kil’dyushkin, A. E. Petukhov, E. A. Litvin, Farmakokin. Farmakodin., No. 2, 36 – 45 (2022).
V. Poulos, W. H. Lockwood, Int. J. Biochem., 12(5) – 6, 959 – 961 (1980).
M. Danton and C. K. Lim, Biomed. Chromatogr., 20(6 – 7), 612 – 621 (2006).
K. Sorte, K. Palandurkar, M. Goyal, et al., J. Clin. Diagn. Res., 3, 2031 – 2035 (2010).
M. Biesaga, K. Pyrzynska, M. Trojanowicz, Talanta, 51, 209 – 224 (2000).
W. Huang, Q. Liu, E.-Y. Zhu, et al., Talanta, 82, 1516 – 1520 (2010).
E. DiPierro, M. DeCanio, R. Mercadante, et al., Diagnostics, 11, 1343 (2021).
L. Chularojanamontri, C. Tuchinda, C. Srisawat, et al., J. Med. Assoc. Thai., 91(12), 1915 – 1919 (2008).
A. Nimesh, V. Agarwal, S. Garg, and M. Mehndiratta, Ind. J. Med. Biochem., 21(2), 136 – 141 (2017).
E. Magi, C. Ianni, P. Rivaro, et al., J. Chromatogr. A, 905, No. 1 – 2, 141 – 149 (2001).
M. Tahoun, C. T. Gee, V. E. McCoy, et al., RSC Adv., 11, 7552 – 7563 (2021).
H. D. Meyer, K. Jacob, W. Vogt, in: XI Int. Congr. of Clin. Chem., 2nd edition. E. Kaiser, F. Gabl, M. M. Müller, P. M. Bayer (eds.) De Gruyter, Berlin, Germany; Boston, MA, USA; Vienna, Austria (2019), pp. 1001 – 1006.
D. T. Zelt, J. A. Owen, G. S. Marks, J. Chromatogr., 189(2), 209 – 116 (1980).
H. de Verneuil, S. Sassa, A. Kappas, J. Biol. Chem., 258(4), 2454 – 2460 (1983).
J. Fyrestam, N. Bjurshammar, E. Paulsson, et al., Anal. Bioanal. Chem., 407, 7013 – 7023 (2015).
C. Taylor, L. K. Duffy, F. G. Plumley, and R. T. Bowyer, Environ. Res., 84(1), 56 – 63 (2000).
Y. Hur, S. Tae, Y. Koh, et al., Mass Spectrometry Lett., 5(2), 42 – 48 (2014).
J. S. Woods and P. L. Simmonds, Curr. Protoc. Toxicol., Chapter 8, Unit 8.9 (2001); doi: https://doi.org/10.1002/0471140856.tx0809s07.
I. San Juan, C. Bruzzone, M. Bizkarguenaga, et al., Br. J. Haematol., 190(5), e265-e267 (2020).
R. Mateo, G. Castells, A. J. Green, et al., J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 810(2), 305 – 311 (2004).
J. To-Figueras, J. D. Phillips, J. M. Gonzalez-López, et al., Br. J. Dermatol., 165(3), 499 – 505 (2011).
ICH Harmonized Tripartite Guidelines, ICH Topic Q2 (R1) “Validation of analytical procedures: Text and methodology, ICH, Geneva (1995).
FDA Guidance Documents “Analytical Procedures and Methods Validation for Drugs and Biologics” FDA(July, 2015).
OFS. 1.1.0012.15 “Validation of analytical methods,” in: State Pharmacopeia of the Russian Federation [in Russian], XIV edition (2018).
Guidelines on the Validation of Analytical Methods for Testing Medicinal Products [in Russian], Approved by decision of the Collegium of Countries of the Eurasian Economic Commission, July 17, 2018, No. 113 (2018).
Guidance on Validation of Drug Analysis Methods [in Russian], Russian Federation Ministry of Health and Social Development, Moscow (2007).
Pharmacopeia (USP-31), General Chapters: Validation of compendial methods.
ICH Q2B, International Conference on Harmonisation, Validation of analytical procedures, Methodology (2002).
Pharmacopeia of the Eurasian Economic Union, 2.1. General pharmacopeia article OFS 5.31. Validation of analytical methods.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 7, pp. 55 – 60, July, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kil’dyushkin, D.A., Litvin, E.A., Sukhanova, A.M. et al. Development and Validation of a Method for Assay of Porphyrins and Their Precursors by HPLC with UV Detection in Human Plasma. Pharm Chem J 57, 1089–1094 (2023). https://doi.org/10.1007/s11094-023-02988-w
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-023-02988-w